Sudarshan Pharma Industries Ltd IPO Message Board (Page 5)

will avoid this as issue is very big and pharma sector has lost the fancy of the investors. and other issues are also there as described by dilip sir.

If this Issue is also like Indong Tea, where earlier issue is revoked due to undersubscription and reissue made in February, though subscribed, left subscribers poorer by 20%, better AVOID.

A correction as per my observation.
Indong Issue was not revoked due to under subscription, but withdrawn prior to its opening. As per some internal news the withdrawal was due to some compliance issues and IPO reopened after the resolving such issues. That's may be a reason for change in promoter's name and others updations in the revised offer documents.

But Sudharsan pharma was revoked due to under subscription, the date extended, price revised and finally withdrawn. So one to one comparison is not ok.
Indong disappointed that's true and many of members in this forum already given avoid msgs for Indong.

1 ya 2 din me grey activities chalu hone vali hai is ipo me.

So be ready guys

So many ifs & buts... So many unanswered questions.... Will wait

In 2019, Company planned and withdrawn IPO main platform listing but now SME platform by changing LM to Gretex formerly called Guinness, many not earned money throguh Gretex MANAGED ipos, since they will not do good market making or by offering little grrom to earn money by IPO investors. For viz latest Earsten Logica Infoway..sme ipo.

Quality Foils IPO Details
Quality Foils IPO Dates14 – 16 March 2023
Quality Foils IPO PriceINR 60 per share
Fresh issue7,54,000 shares (INR 4.52 crore)
Offer For SaleNil
Total IPO size7,54,000 shares (INR 4.52 crore)
Minimum bid (lot size)2,000 shares (INR 120,000)
Face Value INR 10 per share
Retail Allocation50%

This IPO reminds me of situation of Agni Pharma in movie Bazaar..kahi iski bhi wohi haalat na ho jaye

AVOID.

This is Fully arranged ipo

That's why its SME platform with added advantages for company and LM.
Investors should choose basis of performance of Company in Long Term and LM for very very short Term.
In most of the SME, Company is beneficial and not the investors

Some merchant banker are taking sme platform as "Jo mile jaisa mile kro, bus Ghar pr Paisa aana chahiye"..
Merchant banker plays a very vital role in primary market and they should understand their responsibilities.

Those Merchant Bankers will be out of business very soon....people do remember the names of MB and other institutions associated with flop IPOs

Waste IPO , Only sell n apply

Alert for notice🚨
This company trying second time for listing after a failed attempt in 2019. That time tried in NSE Emerge for IPO size of 25.80 crores @ 75/- per share. LM was First Overseas Capital Limited and Karvy Fintech was RTA. The issue was withdrawn after closure of the issue and application money has to be refunded.

Comment for DD: Due to heavy under subscription, Issue stands extended till 24th June 2019. Company has also reduced the price to Rs. 72 per share from Rs. 75 per share, still valuation is very much on the higher side. My conclusion remains the same despite price reduction. - Simply Avoid.

Last time object was to set up a dedicated manufacturing facility for Pharmaceutical Business, Distribution and Warehousing Centre's & Purchase of Corporate Office and owrking capital requirment. This time ony working capital requirment.

CG page link for ref: https://www.chittorgarh.com/ipo/sudarshan-pharma-ipo/992/

or search for Sudarshan Pharma Industries Limited (this time page created as Ltd)

Thanks for your research. Your information and old ipo link of Chittorgarh are helpful to make decision.

Valuation is a issue in this IPO.....will avoid

I think Sudarshan Pharma coming with ipo with fully managed

Promoter cost is low alomost 0...return on net work is bery low
Promoters holding at 54%
Very bad is 7.4 crore demand in tax ans criminal case against director
Irda poor track record

Sudarshan Pharma Ind Ltd
GMP 5 Seller @ 9:15pm # 02/March

Interesting Fact
In 2019 First Overseas Filed IPO
Company PAT 2.3 Cr. In 2019 Valuation 95 Cr.
PE: 40 X

IPO FLOPPED

IN 2023 Gretex Filed IPO

Company PAT 5.2 Cr. In 2023 Valuation 174 Cr.
PE : 34X

Fingers Crossed

Company coming up with such Valuation were the entire Sector Valuation is Struggling. Industries PE is max 10 time.
Many Big Player are down 50-70% from Peak at covid

Retail will Sing
Reminds me of :
Pathan Song
Haamye tooh Looot Leeya ...milkke

Premium 5 seller

I know promoter.... They wanted IPO of 80 cr... company is Not good nor much great products... Simple business....
I request not to apply as they are agressive price ...

Need to be aware of issues...
Issue is completely underwritten..
Sentimental fayada ...